Advertisement
Surgery
Advanced searchSave search
Research Article| Volume 116, ISSUE 6, P966-973, December 1994

Parathyroid imaging with technetium-99m-sestamibi: An initial institutional experience

  • Geoffrey B. Thompson
    Correspondence
    Reprint requests: Geoffrey B. Thompson, MD, Mayo Clinic, 200 First St. SW, Rochester, MN 55905.
    Affiliations
    From the Division of Gastroenterologic and General Surgery, Division of Endocrinology, Metabolism, and Internal Medicine, Rochester, Minn., USA

    Department of Nuclear Medicine, Division of Anatomic Pathology, and Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minn., USA
    Search for articles by this author
  • Brian P. Mullan
    Affiliations
    From the Division of Gastroenterologic and General Surgery, Division of Endocrinology, Metabolism, and Internal Medicine, Rochester, Minn., USA

    Department of Nuclear Medicine, Division of Anatomic Pathology, and Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minn., USA
    Search for articles by this author
  • Clive S. Grant
    Affiliations
    From the Division of Gastroenterologic and General Surgery, Division of Endocrinology, Metabolism, and Internal Medicine, Rochester, Minn., USA

    Department of Nuclear Medicine, Division of Anatomic Pathology, and Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minn., USA
    Search for articles by this author
  • Colum A. Gorman
    Affiliations
    From the Division of Gastroenterologic and General Surgery, Division of Endocrinology, Metabolism, and Internal Medicine, Rochester, Minn., USA

    Department of Nuclear Medicine, Division of Anatomic Pathology, and Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minn., USA
    Search for articles by this author
  • Jon A. van Heerden
    Affiliations
    From the Division of Gastroenterologic and General Surgery, Division of Endocrinology, Metabolism, and Internal Medicine, Rochester, Minn., USA

    Department of Nuclear Medicine, Division of Anatomic Pathology, and Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minn., USA
    Search for articles by this author
  • Michael K. O'Connor
    Affiliations
    From the Division of Gastroenterologic and General Surgery, Division of Endocrinology, Metabolism, and Internal Medicine, Rochester, Minn., USA

    Department of Nuclear Medicine, Division of Anatomic Pathology, and Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minn., USA
    Search for articles by this author
  • John R. Goellner
    Affiliations
    From the Division of Gastroenterologic and General Surgery, Division of Endocrinology, Metabolism, and Internal Medicine, Rochester, Minn., USA

    Department of Nuclear Medicine, Division of Anatomic Pathology, and Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minn., USA
    Search for articles by this author
  • Duane M. Ilstrup
    Affiliations
    From the Division of Gastroenterologic and General Surgery, Division of Endocrinology, Metabolism, and Internal Medicine, Rochester, Minn., USA

    Department of Nuclear Medicine, Division of Anatomic Pathology, and Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minn., USA
    Search for articles by this author
DOI:https://doi.org/10.5555/uri:pii:0039606094902917
Parathyroid imaging with technetium-99m-sestamibi: An initial institutional experience
Previous ArticleUse of preoperative fine-needle aspiration in patients undergoing reoperation for primary hyperparathyroidism
Next ArticlePositron emission tomography with 11 C-methionine in hyperparathyroidism
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Background. The ideal method for preoperative localization of abnormal parathyroid glands has yet to be determined. Technetium-99m-sestamibi, previously used for myocardial perfusion studies, has recently been introduced for parathyroid imaging.
      Methods. From August 1991 to September 1993, 44 patients underwent Tc-99m-sestamibi scanning (45 scans) and surgical exploration for hyperparathyroidism at our institution. These 44 patients form the database for this retrospective study. Twenty-eight patients had persistent hyperparathyroidism, six had recurrent disease, three had prior thyroid operation, and seven underwent first time neck operations. The nature of disease was complex and varied: single gland, 26; primary hyperplasia, 5; multiple endocrine neoplasia type 1, 5; familial, 3; secondary or tertiary, 5. One patient with single gland disease and one patient with multiple endocrine neoplasia type 1 had parathyroid carcinoma. All patients had biochemical confirmation of hyperparathyroidism.
      Results. Twenty-six (58%) of 45 scans accurately predicted the location (s) of all abnormal gland(s) involved (true positive). Surgical removal of these glands was curative. Sixteen (36%) of 45 scans were false negative because they did not show all abnormal glands involved; however, 7 of these 16 scans did localize at least one abnormal gland. The overall sensitivity of this test was 62% when all abnormal glands were considered but increased to 79% with the demonstration of at least one abnormal gland. These values increased to 80% and 90% (p = 0.03), respectively, in the last 20 patients when the injected dose of Tc-99m-sestamibi was increased from 10 to 15 mCi. Thirty-seven of 44 patients were cured after operation. Six of the seven patients who experienced surgical failure had multigland disease, one of which was malignant. Sestamibi scans correctly identified abnormal cervical glands in 18 (58%) of 31 patients and abnormal mediastinal glands in six (75%) of eight patients.
      Conclusions. Tc-99m-sestamibi scanning is helpful in the reoperative setting as an adjunct to localizing abnormal parathyroid tissue. A higher percentage of positive tests occurs in patients with mediastinal and single gland disease. A higher dose of Tc-99m-sestamibi (15 mCi) significantly improves test sensitivity.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • van Heerden J.A.
        • Grant C.S.
        Surgical treatment of primary hyperparathyroidism: an institutional perspective.
        World J Surg. 1991; 15: 688-692
        • Holman B.L.
        • Sporn V.
        • Jones A.G.
        • et al.
        Myocardial imaging with technetium-99m CPI: initial experience in the human.
        J Nucl Med. 1987; 28: 13-18
        • Coakley A.J.
        • Kettle A.G.
        • Wells C.P.
        • O'Doherty M.J.
        • Collins R.E.C.
        99Tcm-sestamibi—a new agent for parathyroid imaging.
        Nucl Med Commun. 1989; 10: 791-794
        • Taillefer R.
        • Boucher Y.
        • Potvin C.
        • Lambert R.
        Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study).
        J Nucl Med. 1992; 33: 1801-1809
        • Wei J.P.
        • Burke G.J.
        • Mansberger A.R.
        Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands.
        Surgery. 1992; 112: 1111-1116
        • Casas A.T.
        • Burke G.J.
        • Mansberger A.R.
        • Wei J.P.
        Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism.
        Am Surg. 1994; 60: 12-17
        • Casas A.T.
        • Burke G.J.
        • Sathyanarayana Mansberger A.R.
        • Wei J.P.
        Prospective comparison of technetium-99m-sestamibi/iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism.
        Am J Surg. 1993; 166: 369-373
        • Weber C.J.
        • Vansant J.
        • Alazraki N.
        • et al.
        Value of technetium99m-sestamibi-iodine 123 imaging in reoperative parathyroid surgery.
        Surgery. 1993; 114: 1011-1018
        • Wei J.P.
        • Burke G.J.
        • Mansberger Jr, A.R.
        Preoperative imaging of abnormal parathyroid glands in patients with hyperparathyroid disease using combination Tc-99m-pertechnetate and Tc99m-sestamibi radionuclide scans.
        Ann Surg. 1994; 219: 568-573
        • O'Doherty M.J.
        • Kettle A.G.
        • Wells P.
        • Collins R.E.C.
        • Coakley A.J.
        Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies.
        J Nucl Med. 1992; 33: 313-318
        • O'Doherty M.J.
        • Kettle A.G.
        • Wells C.P.
        • Collins R.E.G.
        • Coakley A.J.
        99Tcm-sestamibi for parathyroid imaging.
        Nucl Med Commun. 1990; 11 ([Abstract]): 195
        • Geatti O.
        • Antonucci F.
        • Proto G.
        • Cattaruzzi E.
        • Orsolon P.G.
        • Guerra U.P.
        99m-TC-MIBI in parathyroid scintigraphy.
        Eur J Noel Med. 1991; 18 ([Abstract]): 582
        • Potchen E.J.
        Parathyroid imaging-current status and future prospects.
        J Nucl Med. 1992; 33: 1807-1809
        • Balon H.R.
        • Fink-Bennett D.
        • Stoffer S.S.
        Technetium-99m-sestamibi uptake by recurrent Hürthle cell carcinoma of the thyroid.
        J Nucl Med. 1992; 33: 1393-1395
        • Menta C.R.
        • Patel N.R.
        A network algorithm for the exact treatment of Fishers exact test in RxC contingency tables.
        J Am Stat Assoc. 1983; 78: 427-434
        • Krubsack A.J.
        • Wilson S.D.
        • Lawson T.L.
        • et al.
        Prospective comparison of radionuclide, computed tomographic, sonography, and magnetic resonance localization of parathyroid tumors.
        Surgery. 1989; 106: 639-646
        • van Heerden J.A.
        • James E.M.
        • Karsell P.R.
        • Charboneau J.W.
        • Grant C.S.
        • Purnell D.C.
        Small-part ultrasonography in primary hyperparathyroidism: initial experience.
        Ann Surg. 1982; 195: 774-780
        • Grant C.S.
        • van Heerden J.A.
        • Charboneau J.W.
        • et al.
        Clinical management of persistent and/or recurrent primacy hyperparathyroidism.
        World J Surg. 1986; 10: 555-565
        • Hauty M.
        • Swartz K.
        • McClung M.
        • et al.
        Technetium-thallium scintiscanning for localization of parathyroid adenomas and hyperplasia, a reappraisal.
        Am J Surg. 1987; 153: 479-486
        • Chia M.L.
        • Kronange J.F.
        • Piwnica-Worms D.
        Effect of mitochondrial and plasma-membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium in cultured mouse fibroblasts.
        J Nucl Med. 1990; 31: 1646-1653
        • Reading C.C.
        • Charboneau J.W.
        • James E.M.
        • et al.
        High-resolution parathyroid sonography.
        AJR. 1982; 139: 539-546
        • Stark D.D.
        • Moss A.A.
        • Gooding G.A.
        • Clark O.H.
        Parathyroid scanning by computed tomography.
        Radiology. 1983; 148: 297-299
        • Auffermann W.
        • Gooding G.A.W.
        • Okerlund M.D.
        • et al.
        Diagnosis of recurrent hyperparathyroidism: comparison of MR imaging and other imaging techniques.
        AJR. 1988; 150: 1027-1033
        • Doppman J.L.
        Parathyroid localization: arteriography and venous sampling.
        Radiol Clin North Am. 1976; 14: 163-188
        • Kao P.C.
        • van Heerden J.A.
        • Taylor R.L.
        Intraoperative monitoring of parathyroid procedures by a 15-minute parathyroid hormone immunochemiluminometric assay.
        in: 2nd ed. Mayo Clin Proc. 69. 1994: 532-537

      Article info

      Footnotes

      ☆Presented at the Fifteenth Annual Meeting of the American Association of Endocrine Surgeons, Dearborn, Mich., April 17–19, 1994.

      Identification

      DOI: https://doi.org/10.5555/uri:pii:0039606094902917

      Copyright

      © 1994 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX